Legal & General Group
XFOR icon

Legal & General Group’s X4 Pharmaceuticals XFOR Stock Holding History

Legal & General Group’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-620
Closed -$4.4K – 3556
2025
Q1 		$4.4K Hold
620
– – ﹤0.01% 3296
2024
Q4 		$13.7K Hold
620
– – ﹤0.01% 3169
2024
Q3 		$12.5K Hold
620
– – ﹤0.01% 3226
2024
Q2 		$10.8K Buy
620
+242
+64% +$7.92K ﹤0.01% 3284
2024
Q1 		$15.7K Hold
378
– – ﹤0.01% 3062
2023
Q4 		$9.5K Hold
378
– – ﹤0.01% 3246
2023
Q3 		$12.3K Sell
378
-69
-15% -$3.01K ﹤0.01% 3224
2023
Q2 		$26K Buy
+447
New +$23K ﹤0.01% 3002
2021
Q2 		– Sell
-47
Closed -$12K – 3665
2021
Q1 		$12K Hold
47
– – ﹤0.01% 3331
2020
Q4 		$9K Hold
47
– – ﹤0.01% 3376
2020
Q3 		$10K Sell
47
-15
-24% -$3.6K ﹤0.01% 3240
2020
Q2 		$17K Sell
62
-17
-22% -$4.66K ﹤0.01% 3141
2020
Q1 		$21K Sell
79
-4
-5% -$1.14K ﹤0.01% 2897
2019
Q4 		$27K Buy
83
+17
+26% +$6.1K ﹤0.01% 3097
2019
Q3 		$25K Buy
66
+27
+69% +$10.7K ﹤0.01% 3060
2019
Q2 		$17K Buy
39
+35
+875% +$17.8K ﹤0.01% 3261
2019
Q1 		$2K Hold
4
– – ﹤0.01% 3336
2018
Q4 		$2K Hold
4
– – ﹤0.01% 3372
2018
Q3 		$1K Hold
4
– – ﹤0.01% 3385
2018
Q2 		$3K Hold
4
– – ﹤0.01% 3341
2018
Q1 		$18K Buy
+4
New +$11.6K ﹤0.01% 3132

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Legal & General Group's XFOR Position: Q2 2025 in Review

Legal & General Group sold out of X4 Pharmaceuticals (XFOR) in Q2 2025, closing a stake of 620 shares — an estimated $4.4K sold.

Legal & General Group first reported a position in XFOR in Q1 2018 and held it in 21 quarters. The position peaked at $27K in Q4 2019. 51 funds tracked by Wall St. Rank hold XFOR as of Q2 2025.

  • Legal & General Group reported no remaining X4 Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 620 X4 Pharmaceuticals shares in Q2 2025, an estimated $4.4K.
  • Legal & General Group first reported a position in X4 Pharmaceuticals in Q1 2018 and held it in 21 quarters.
  • Legal & General Group's X4 Pharmaceuticals position peaked at $27K in Q4 2019.
  • 51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.